Citigroup: C-Corp Conversion Raises 'Absolute Upside' For KKR
One logical corollary of the tax reform is companies scrambling to take advantage of reduced tax rates.
KKR & Co. L.P. Unit (NYSE: KKR) recently announced Q1 results and also communicated the decision to convert itself from a partnership to a corporation, effective July 1, in a bid to broaden its investor base, simplify its structure and make it easier for investing in its shares.
The Analyst
Citigroup analyst William Katz upgraded KKR from Neutral to Buy and increased his price target from to $23.50 to $27. The analyst is removing the "high-risk" designation.
The Thesis
KKR's C-Corp conversion will increase relevance of the sector, leading to positive revaluation among alternative asset managers, Katz said in a note. The analyst also sees the conversion increasing absolute upside for KKR.
"KKR's C-Corp conversion should increase Long Only appeal but does not go far enough in our view," the analyst said.
The analyst raised his 2018 ENI estimates from $1.81 to $2.31 and maintained his 2019 estimate unchanged at $2.92, but lowered his 2020 estimate from $2.92 to $2.79.
Citi attributed the upward revision to the price target to the updated NAVs, increased balance sheet value, lower cost of capital to discount performance fees and tax benefits on the company's C-Corp conversion.
The Price Action
KKR shares have added 4.2 percent in the year-to-date period. The stock traded around $22.40 at time of publication, up 3.7 percent on the day.
Related Links:
What Saudi Arabia's Investment With Blackstone Means For The Stock
Market Volatility Helps Big Banks: A Q1 Earnings Roundup
Latest Ratings for KKR
May 2018 | Citigroup | Upgrades | Neutral | Buy |
May 2018 | Credit Suisse | Maintains | Outperform | Outperform |
May 2018 | Deutsche Bank | Maintains | Hold | Hold |
View More Analyst Ratings for KKR
View the Latest Analyst Ratings
See more from Benzinga
Benzinga's Daily Biotech Pulse: Verastem Uprooted On Stock Offering, Titan Pharma Earnings
Morgan Stanley Sees Strong Growth Ahead For Pivotal Software
© 2018 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
